Universal intraoperative systemic heparin administration during liver transplantation: A case series

Liver Transpl. 2024 Jun 1;30(6):661-667. doi: 10.1097/LVT.0000000000000329. Epub 2024 Jan 9.

Authors

Sarah Diaz¹, Callie VanWinkle¹, Emily Roney¹, Sathish S Kumar², Nicholas J Douville^{2

3}, Michael Englesbe^{3

4}, Christopher J Sonnenday^{3

4}, Seth Waits^{3

4}, Sara L Schaefer^{3

4}

Affiliations

¹ University of Michigan Medical School, Ann Arbor, Michigan, USA.
² Department of Anesthesia, University of Michigan, Ann Arbor, Michigan, USA.
³ Department of Surgery, Section of Transplantation, Michigan Medicine, Ann Arbor, Michigan, USA.
⁴ Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan, USA.

PMID: 38190234
DOI: 10.1097/LVT.0000000000000329

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Anticoagulants* / administration & dosage
Anticoagulants* / adverse effects
Female
Heparin* / administration & dosage
Heparin* / adverse effects
Humans
Intraoperative Care / methods
Liver Transplantation* / adverse effects
Liver Transplantation* / methods
Male
Middle Aged
Treatment Outcome
Young Adult

Substances

Anticoagulants
Heparin